Impaired Peroxisome Proliferator-activated Receptor-gamma Contributes to Phenotypic Modulation of Vascular Smooth Muscle Cells During Hypertension

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2010 Mar 10

PMID 20212046

Citations 19

Authors

Lili Zhang

Peng Xie

Jingzhou Wang

Qingwu Yang

Chuanqin Fang

Shuang Zhou

Jingcheng Li

Affiliations

Soon will be listed here.

Abstract

The phenotypic modulation of vascular smooth muscle cells (VSMCs) plays a pivotal role in hypertension-induced vascular changes including vascular remodeling. The precise mechanisms underlying VSMC phenotypic modulation remain elusive. Here we test the role of peroxisome proliferator-activated receptor (PPAR)-gamma in the VSMC phenotypic modulation during hypertension. Both spontaneously hypertensive rat (SHR) aortas and SHR-derived VSMCs exhibited reduced PPAR-gamma expression and excessive VSMC phenotypic modulation identified by reduced contractile proteins, alpha-smooth muscle actin (alpha-SMA) and smooth muscle 22alpha (SM22alpha), and enhanced proliferation and migration. PPAR-gamma overexpression rescued the expression of alpha-SMA and SM22alpha, and inhibited the proliferation and migration in SHR-derived VSMCs. In contrast, PPAR-gamma silencing exerted the opposite effect. Activating PPAR-gamma using rosiglitazone in vivo up-regulated aortic alpha-SMA and SM22alpha expression and attenuated aortic remodeling in SHRs. Increased activation of phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) signaling was observed in SHR-derived VSMCs. PI3K inhibitor LY294002 rescued the impaired expression of contractile proteins, and inhibited proliferation and migration in VSMCs from SHRs, whereas constitutively active PI3K mutant had the opposite effect. Overexpression or silencing of PPAR-gamma inhibited or excited PI3K/Akt activity, respectively. LY294002 counteracted the PPAR-gamma silencing induced proliferation and migration in SHR-derived VSMCs, whereas active PI3K mutant had the opposite effect. In contrast, reduced proliferation and migration by PPAR-gamma overexpression were reversed by the active PI3K mutant, and further inhibited by LY294002. We conclude that PPAR-gamma inhibits VSMC phenotypic modulation through inhibiting PI3K/Akt signaling. Impaired PPAR-gamma expression is responsible for VSMC phenotypic modulation during hypertension. These findings highlight an attractive therapeutic target for hypertension-related vascular disorders.

Citing Articles

miR-145 attenuates phenotypic transformation of aortic vascular smooth muscle cells to prevent aortic dissection.

Qiu Z, He J, Chai T, Zhang Y, Zhou H, Zheng H J Clin Lab Anal. 2021; 35(12):e23773.

PMID: 34767671 PMC: 8649326. DOI: 10.1002/jcla.23773.

Targeting smooth muscle cell phenotypic switching in vascular disease.

Chakraborty R, Chatterjee P, Dave J, Ostriker A, Greif D, Rzucidlo E JVS Vasc Sci. 2021; 2:79-94.

PMID: 34617061 PMC: 8489222. DOI: 10.1016/j.jvssci.2021.04.001.

Jujuboside B Inhibits Neointimal Hyperplasia and Prevents Vascular Smooth Muscle Cell Dedifferentiation, Proliferation, and Migration Activation of AMPK/PPAR-γ Signaling.

Ji Z, Li J, Wang J Front Pharmacol. 2021; 12:672150.

PMID: 34248626 PMC: 8266264. DOI: 10.3389/fphar.2021.672150.

Pyrogallol-Phloroglucinol-6,6-Bieckolon Attenuates Vascular Smooth Muscle Cell Proliferation and Phenotype Switching in Hyperlipidemia through Modulation of Chemokine Receptor 5.

Oh S, Son M, Park C, Jang J, Son K, Byun K Mar Drugs. 2020; 18(8).

PMID: 32727125 PMC: 7460451. DOI: 10.3390/md18080393.

Involvement of the MiR-181b-5p/HMGB1 Pathway in Ang II-induced Phenotypic Transformation of Smooth Muscle Cells in Hypertension.

Li F, Zhang C, Luo X, Peng J, Yang T Aging Dis. 2019; 10(2):231-248.

PMID: 31011475 PMC: 6457049. DOI: 10.14336/AD.2018.0510.

References

Potenza M, Marasciulo F, Tarquinio M, Quon M, Montagnani M . Treatment of spontaneously hypertensive rats with rosiglitazone and/or enalapril restores balance between vasodilator and vasoconstrictor actions of insulin with simultaneous improvement in hypertension and insulin resistance. Diabetes. 2006; 55(12):3594-603. DOI: 10.2337/db06-0667. View

Chen L, Necela B, Su W, Yanagisawa M, Anastasiadis P, Fields A . Peroxisome proliferator-activated receptor gamma promotes epithelial to mesenchymal transformation by Rho GTPase-dependent activation of ERK1/2. J Biol Chem. 2006; 281(34):24575-87. DOI: 10.1074/jbc.M604147200. View

Chuang C, Yang R, Tsai K, Ho F, Liu S . Hyperglycemia enhances adipogenic induction of lipid accumulation: involvement of extracellular signal-regulated protein kinase 1/2, phosphoinositide 3-kinase/Akt, and peroxisome proliferator-activated receptor gamma signaling. Endocrinology. 2007; 148(9):4267-75. DOI: 10.1210/en.2007-0179. View

Nakagawa M, Ohno T, Maruyama R, Okubo M, Nagatsu A, Inoue M . Sesquiterpene lactone suppresses vascular smooth muscle cell proliferation and migration via inhibition of cell cycle progression. Biol Pharm Bull. 2007; 30(9):1754-7. DOI: 10.1248/bpb.30.1754. View

Xu X, Ha C, Wong C, Wang W, Hausser A, Pfizenmaier K . Angiotensin II stimulates protein kinase D-dependent histone deacetylase 5 phosphorylation and nuclear export leading to vascular smooth muscle cell hypertrophy. Arterioscler Thromb Vasc Biol. 2007; 27(11):2355-62. PMC: 4259271. DOI: 10.1161/ATVBAHA.107.151704. View

Hegner B, Lange M, Kusch A, Essin K, Sezer O, Schulze-Lohoff E . mTOR regulates vascular smooth muscle cell differentiation from human bone marrow-derived mesenchymal progenitors. Arterioscler Thromb Vasc Biol. 2008; 29(2):232-8. DOI: 10.1161/ATVBAHA.108.179457. View

Mitra A, Jia G, Gangahar D, Agrawal D . Temporal PTEN inactivation causes proliferation of saphenous vein smooth muscle cells of human CABG conduits. J Cell Mol Med. 2008; 13(1):177-87. PMC: 2782896. DOI: 10.1111/j.1582-4934.2008.00311.x. View

Lee S, Kim W, Moon S . TNF-alpha regulates vascular smooth muscle cell responses in genetic hypertension. Int Immunopharmacol. 2009; 9(7-8):837-43. DOI: 10.1016/j.intimp.2009.03.010. View

Hayashi K, Naiki T . Adaptation and remodeling of vascular wall; biomechanical response to hypertension. J Mech Behav Biomed Mater. 2009; 2(1):3-19. DOI: 10.1016/j.jmbbm.2008.05.002. View

10.

Fernandez-Hernando C, Jozsef L, Jenkins D, Di Lorenzo A, Sessa W . Absence of Akt1 reduces vascular smooth muscle cell migration and survival and induces features of plaque vulnerability and cardiac dysfunction during atherosclerosis. Arterioscler Thromb Vasc Biol. 2009; 29(12):2033-40. PMC: 2796372. DOI: 10.1161/ATVBAHA.109.196394. View

11.

Choi K, Kim J, Song N, Son J, Hwang M, Byun S . Phosphoinositide 3-kinase is a novel target of piceatannol for inhibiting PDGF-BB-induced proliferation and migration in human aortic smooth muscle cells. Cardiovasc Res. 2009; 85(4):836-44. DOI: 10.1093/cvr/cvp359. View

12.

Barroso I, Gurnell M, Crowley V, Agostini M, Schwabe J, Soos M . Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature. 2000; 402(6764):880-3. DOI: 10.1038/47254. View

13.

Law R, Goetze S, Xi X, Jackson S, Kawano Y, Demer L . Expression and function of PPARgamma in rat and human vascular smooth muscle cells. Circulation. 2000; 101(11):1311-8. DOI: 10.1161/01.cir.101.11.1311. View

14.

Morales-Ruiz M, Fulton D, Sowa G, Languino L, Fujio Y, Walsh K . Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circ Res. 2000; 86(8):892-6. DOI: 10.1161/01.res.86.8.892. View

15.

Hattori Y, Akimoto K, Kasai K . The effects of thiazolidinediones on vascular smooth muscle cell activation by angiotensin II. Biochem Biophys Res Commun. 2000; 273(3):1144-9. DOI: 10.1006/bbrc.2000.3084. View

16.

Wakino S, Kintscher U, Kim S, Yin F, Hsueh W, Law R . Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cells. J Biol Chem. 2000; 275(29):22435-41. DOI: 10.1074/jbc.M910452199. View

17.

Dimmeler S, Dernbach E, Zeiher A . Phosphorylation of the endothelial nitric oxide synthase at ser-1177 is required for VEGF-induced endothelial cell migration. FEBS Lett. 2000; 477(3):258-62. DOI: 10.1016/s0014-5793(00)01657-4. View

18.

Kliewer S, Xu H, Lambert M, Willson T . Peroxisome proliferator-activated receptors: from genes to physiology. Recent Prog Horm Res. 2001; 56:239-63. DOI: 10.1210/rp.56.1.239. View

19.

Diep Q, Schiffrin E . Increased expression of peroxisome proliferator-activated receptor-alpha and -gamma in blood vessels of spontaneously hypertensive rats. Hypertension. 2001; 38(2):249-54. DOI: 10.1161/01.hyp.38.2.249. View

20.

Goetze S, Kintscher U, Kim S, Meehan W, Kaneshiro K, Collins A . Peroxisome proliferator-activated receptor-gamma ligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase/mitogen-activated protein kinase-regulated steps in vascular smooth muscle cell migration. J Cardiovasc Pharmacol. 2001; 38(6):909-21. DOI: 10.1097/00005344-200112000-00013. View